Display options
Cite
Kamal K, Charrow A, LaChance A. Amending iPLEDGE: Why "Abstaining from Abstinence" May Harm LGBTQ+ Patients. J Clin Aesthet Dermatol. 2021;14(2):12
Kamal, K., Charrow, A., & LaChance, A. (2021). Amending iPLEDGE: Why "Abstaining from Abstinence" May Harm LGBTQ+ Patients. The Journal of clinical and aesthetic dermatology, 14(2), 12.
Kamal, Kanika, et al. "Amending iPLEDGE: Why "Abstaining from Abstinence" May Harm LGBTQ+ Patients." The Journal of clinical and aesthetic dermatology vol. 14,2 (2021): 12.
Kamal K, Charrow A, LaChance A. Amending iPLEDGE: Why "Abstaining from Abstinence" May Harm LGBTQ+ Patients. J Clin Aesthet Dermatol. 2021 Feb;14(2):12. Epub 2021 Feb 01. PMID: 34221220; PMCID: PMC8211342.
Copy Download .nbib Format: NLM
Share it on

J Clin Aesthet Dermatol. 2021 Feb;14(2):12. Epub 2021 Feb 01.

Amending iPLEDGE: Why "Abstaining from Abstinence" May Harm LGBTQ+ Patients.

The Journal of clinical and aesthetic dermatology

Kanika Kamal, Alexandra Charrow, Avery LaChance

Affiliations

  1. Ms. Kamal is with Harvard Medical School in Boston, Massachusetts. Drs. Charrow and LaChance are with the Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

PMID: 34221220 PMCID: PMC8211342

[No abstract available.]

Conflict of interest statement

FUNDING:No funding was provided for this article. DISCLOSURES.: The authors declare no conflicts of interest related to the content of this article.

References

  1. J Youth Adolesc. 2009 Aug;38(7):1001-14 - PubMed
  2. LGBT Health. 2017 Feb;4(1):4-10 - PubMed
  3. J Clin Aesthet Dermatol. 2020 Jun;13(6):54-56 - PubMed
  4. J Gen Intern Med. 1998 Mar;13(3):182-5 - PubMed

Publication Types